Cyrille Leperlier
Director/Board Member at NUCANA PLC
Net worth: - $ as of 30/03/2024
Profile
Cyrille Raymond George Leperlier is currently the Chief Executive Officer at Divlal SAS since 2020 and an Independent Non-Executive Director at NuCana Plc since 2018.
Previously, he worked as a Medical Director at Rhone-Poulenc Rorer, Inc. and Sanofi-Aventis Japan from 2004 to 2019, where he held the position of Medical Director from 2014 to 2019.
He obtained a graduate and doctorate degree from the University of Paris Jussieu.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
NUCANA PLC
-.--% | 30/12/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Cyrille Leperlier active positions
Companies | Position | Start |
---|---|---|
NUCANA PLC | Director/Board Member | 30/04/2018 |
Divlal SAS | Chief Executive Officer | 31/05/2020 |
Former positions of Cyrille Leperlier
Companies | Position | End |
---|---|---|
Sanofi-Aventis Japan | Chief Tech/Sci/R&D Officer | 30/11/2019 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Chief Tech/Sci/R&D Officer | - |
Training of Cyrille Leperlier
University of Paris Jussieu | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NUCANA PLC | Health Technology |
Private companies | 3 |
---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
Sanofi-Aventis Japan | |
Divlal SAS |
- Stock Market
- Insiders
- Cyrille Leperlier